Liebers and colleagues present a prospective non-interventional trial in 80 individuals with hematologic cancer investigating the potential of ex vivo drug response profiling and show it to be clinically feasible.
- Nora Liebers
- Peter-Martin Bruch
- Sascha Dietrich